Clinical Trial Update: Clinical Utility and Safety of Human Umbilical Cord Mesenchymal Stem Cell Secretome in Moderate Neurocognitive Impairment (Dementia) [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety and potential clinical utility of human umbilical cord mesenchymal stem cell secretome in individuals with moderate dement…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia

Drugs mentioned

• Human Umbilical Cord Mesenchymal Stem Cell Secretome (mesenchymal stem cell secretome)

Snippet

Sponsor: Baermed | Conditions: Dementia, Moderate Dementia | Phase 1 | Status: NOT_YET_RECRUITING